Janney Montgomery Scott’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$316K Sell
18,208
-2,100
-10% -$39.7K ﹤0.01% 2342
2025
Q4
$383K Hold
20,308
﹤0.01% 2386
2025
Q3
$295K Sell
20,308
-840
-4% -$12K ﹤0.01% 2506
2025
Q2
$413K Hold
21,148
﹤0.01% 2145
2025
Q1
$375K Buy
+21,148
New +$455K ﹤0.01% 2173
2024
Q4
Sell
-21,463
Closed -$670K 2713
2024
Q3
$670K Hold
21,463
﹤0.01% 1765
2024
Q2
$333K Sell
21,463
-1,050
-5% -$12.7K ﹤0.01% 2151
2024
Q1
$238K Buy
+22,513
New +$225K ﹤0.01% 2475
2022
Q2
Sell
-6,195
Closed -$229K 2324
2022
Q1
$229K Sell
6,195
-320
-5% -$12.5K ﹤0.01% 2018
2021
Q4
$296K Buy
+6,515
New +$340K ﹤0.01% 2006
2018
Q1
Sell
-12,308
Closed -$90K 1944
2017
Q4
$90K Buy
+12,308
New +$76.7K ﹤0.01% 1885

Other funds holding CDNA

Janney Montgomery Scott's CDNA Position: Q1 2026 in Review

Janney Montgomery Scott reduced its CareDx (CDNA) stake by 10% in Q1 2026, selling an estimated $39.7K and leaving 18,208 shares worth $316K. The position accounts for ﹤0.01% of the portfolio, ranked #2342.

Janney Montgomery Scott first reported a position in CDNA in Q4 2017 and has held it in 11 quarters since. The position peaked at $670K in Q3 2024. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Janney Montgomery Scott held 18,208 shares of CareDx worth $316K as of Q1 2026.
  • Janney Montgomery Scott sold 2,100 CareDx shares in Q1 2026, an estimated $39.7K.
  • CareDx made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #2342 holding.
  • Janney Montgomery Scott first reported a position in CareDx in Q4 2017 and has held it in 11 quarters since.
  • Janney Montgomery Scott's CareDx position peaked at $670K in Q3 2024.
  • 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.